Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | ZTS | TAK | UTHR | CTLT |
| Company | Neurocrine Bioscienc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Catalent Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 141.97 | 174.05 | 13.28 | 272.03 | 55.30 |
| High | 142.86 | 174.66 | 13.28 | 274.48 | 55.50 |
| Low | 140.51 | 172.58 | 13.21 | 270.26 | 55.16 |
| Last | 142.29 | 174.06 | 13.22 | 274.26 | 55.37 |
| Change | +0.38 | +0.35 | -0.09 | +2.04 | +0.12 |
| % Change | +0.27% | +0.20% | -0.68% | +0.75% | +0.22% |
| Volume | 641,900 | 1,999,400 | 1,009,700 | 329,200 | 1,079,400 |
| 20-Day Average Volume | 781,755 | 3,430,760 | 1,466,920 | 564,385 | 1,657,210 |
| Previous Close | 141.91 | 173.71 | 13.31 | 272.22 | 55.25 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 139.38 | 163.19 | 13.25 | 254.75 | 55.96 |
| 20-Day Raw Stochastic | 78.18% | 96.92% | 62.50% | 98.23% | 13.38% |
| 20-Day Relative Strength | 55.66% | 58.92% | 44.40% | 69.29% | 44.20% |
| Weighted Alpha | +49.53 | -3.53 | -18.61 | +31.53 | +46.10 |
| Today's Opinion | 100% Buy | 56% Sell | 100% Sell | 100% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 56% Sell | 88% Sell | 100% Buy | 40% Buy |
| Last Month's Opinion | 40% Buy | 88% Sell | 100% Sell | 88% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.09% since 05/10/24 | +2.97% since 05/10/24 | -0.23% since 05/10/24 | +3.78% since 05/10/24 | -0.79% since 05/10/24 |
| Low | 134.79 on 05/14/24 | 167.80 on 05/13/24 | 13.10 on 05/13/24 | 263.56 on 05/13/24 | 55.16 on 05/17/24 |
| High | 142.86 on 05/17/24 | 174.99 on 05/15/24 | 13.49 on 05/14/24 | 275.00 on 05/15/24 | 56.00 on 05/14/24 |
| 1-Month | |||||
| %Chg | +6.80% since 04/17/24 | +14.56% since 04/17/24 | +0.53% since 04/17/24 | +16.55% since 04/17/24 | -1.05% since 04/17/24 |
| Low | 130.13 on 04/19/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 233.27 on 04/24/24 | 55.16 on 05/17/24 |
| High | 145.22 on 05/01/24 | 174.99 on 05/15/24 | 13.49 on 05/14/24 | 275.00 on 05/15/24 | 56.73 on 05/07/24 |
| 3-Month | |||||
| %Chg | +7.54% since 02/16/24 | -7.61% since 02/16/24 | -9.58% since 02/16/24 | +27.72% since 02/16/24 | -4.76% since 02/16/24 |
| Low | 129.15 on 03/01/24 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 213.75 on 02/20/24 | 55.16 on 05/17/24 |
| High | 148.37 on 03/21/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 275.00 on 05/15/24 | 59.28 on 02/23/24 |
| 6-Month | |||||
| %Chg | +30.61% since 11/17/23 | -0.42% since 11/17/23 | -5.23% since 11/17/23 | +19.80% since 11/17/23 | +38.88% since 11/17/23 |
| Low | 108.14 on 11/20/23 | 144.80 on 04/22/24 | 12.77 on 05/09/24 | 208.62 on 02/08/24 | 36.74 on 12/12/23 |
| High | 148.37 on 03/21/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 275.00 on 05/15/24 | 60.20 on 02/05/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,319,639 | 79,422,712 | 41,839,144 | 12,165,075 | 10,020,862 |
| Shares Outstanding, K | 100,637 | 456,295 | 3,164,837 | 44,356 | 180,980 |
| Annual Sales | 1,887,100,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 4,263,000,000 |
| Annual Net Income | 249,700,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | -256,000,000 |
| Last Quarter Sales | 515,300,000 | 2,190,000,000 | 5,397,000,000 | 677,700,000 | 1,074,000,000 |
| Last Quarter Net Income | 43,400,000 | 599,000,000 | -91,000,000 | 306,600,000 | -101,000,000 |
| 60-Month Beta | 0.28 | 0.86 | 0.56 | 0.54 | 1.18 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.42 on 05/01/24 | 1.38 on 05/02/24 | 0.00 on 05/09/24 | 6.17 on 05/01/24 | -0.06 on 05/08/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 05/09/24 | 05/01/24 | 06/10/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 39.09 | 32.23 | 8.53 | 12.87 | 0.00 |